SynthesisEuropean journal of medical research2025
Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global perspectives and clinical trends in Qigong research: a bibliometric and visual analysis (2005-2025).Frontiers in medicine · 2026Pooled it
- Exercise After Coronary Stenting: Potential Effects on in-Stent Restenosis.Current atherosclerosis reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo systematically evaluate the effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention (PCI).
methodsFrom the time the database was constructed to May 28, 2025, Eight databases and two registry systems, including Web of Science, Cochrane Library, PubMed, Embase, China National Knowledge Infrastructure (CNKI), Wanfang database, China Science and Technology Journal Database (VIP), Chinese Biomedical Literature database (CBM), Clinical Trials, and the China Clinical Trials Registry were searched-clinical randomized controlled trials (RCTs) of Baduanjin in treating patients after PCI were retrieved. The primary outcomes were the 6-min walk test (6MWT) and left ventricular ejection fraction (LVEF). Secondary outcomes were Major adverse cardiovascular event (MACE), Seattle Angina Questionnaire (SAQ), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Anaerobic threshold (AT), Metabolic equivalent of task (METs), and Maximal oxygen consumption (VO
resultsA total of 56 RCTs involving 5152 patients were included in the study. Compared with the control group, the Baduanjin group showed superior improvement in LVEF (MD = 5.55%, 95% CI [4.28%, 6.82%], P < 0.01, I
conclusionsBaduanjin can improve cardiopulmonary function, alleviate clinical symptoms, improve quality of life, adjust mental state, and reduce the incidence of MACE in patients after PCI. SYSTEMATIC REVIEW REGISTRATION: CRD42024626379.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.